Semi-annual Report for 2026
Filed with SSE · · 173 pages · Chinese
Henan Lingrui Pharmaceutial Co., Ltd. on 6ix
Earlier from Henan Lingrui Pharmaceutial
- Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major Shareholder
- Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application
- Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
- Announcement on Implementation of Dividend Distribution for 2025
Later from Henan Lingrui Pharmaceutial
- Announcement on Pledge of Certain Shares Held by Major Shareholder
- (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge of Certain Shares Held by Major Shareholder
- (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
- (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Report for Q3 2026
Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.
Follow Henan Lingrui Pharmaceutial